SHORT REPORT

Apolipoprotein E polymorphism in German patients with frontotemporal degeneration

M Riemenschneider¹, J Diehl², U Müller³, H Förstl² and A Kurz²

¹ Neurochemistry and Neurogenetics Laboratory, Department of Psychiatry and Psychotherapy, Technische Universität München, Germany
² Department of Psychiatry and Psychotherapy, Technische Universität München, Germany
³ Department of Human Genetics, Justus Liebig Universität Giessen, Germany

Correspondence to:
Correspondence to:
Dr M Riemenschneider, Neurochemistry and Neurogenetics Laboratory, Department of Psychiatry and Psychotherapy, Technische Universität München, Ismaningerstrasse 22, 81675 Munich, Germany;
m.riemenschneider{at}lrz.tu-muenchen.de

Objectives: The apolipoprotein E (apoE) polymorphism, designated as 2, 3, 4, is a genetic risk factor associated with several forms of dementia. Inconclusive results have been reported in patients with frontotemporal degeneration which prompted this study of the apoE polymorphism in a German sample with frontotemporal degeneration.

Methods: the frequencies of the 2 and 4 alleles and the effect of these alleles on the age at onset in 52 patients with frontotemporal degeneration who underwent a thorough diagnostic examination and in 182 cognitively healthy age matched controls were assessed. Genotype comparisons between the groups were performed using multiple logistic regression analysis. Ages at onset according to the apoE genotype were compared by linear regression analysis.

Results: In patients with frontotemporal degeneration apoE 2 and 4 allele frequencies were 9.6% each, whereas the corresponding frequencies in controls were 9.6% and 9.9%, respectively. There was no significant difference in either 2 or 4 allele frequency between the groups. Age at onset was highest in patients with the 2/3 genotype (61.3 years) followed by patients with the 3/3 (58.3 years) and was lowest in patients with the 3/4 genotype (56.4 years) but the differences failed to reach statistical significance.

Conclusion: Allelic variants of the apoE gene do not modulate occurrence or age at onset in this sample of German patients with frontotemporal degeneration.

Keywords: frontotemporal degeneration; apolipoprotein E genotype

Abbreviations: apoE, apolipoprotein E

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Agosta, F., Vossel, K. A., Miller, B. L., Migliaccio, R., Bonasera, S. J., Filippi, M., Boxer, A. L., Karydas, A., Possin, K. L., Gorno-Tempini, M. L. (2009). Apolipoprotein E {varepsilon}4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia. Proc. Natl. Acad. Sci. USA 106: 2018-2022 [Abstract] [Full Text]  
• Srinivasan, R, Davidson, Y, Gibbons, L, Payton, A, Richardson, A M T, Varma, A, Julien, C, Stopford, C, Thompson, J, Horan, M A, Pendleton, N, Pickering-Brown, S M, Neary, D, Snowden, J S, Mann, D M A (2006). The apolipoprotein E {varepsilon}4 allele selectively increases the risk of frontotemporal lobar degeneration in males. J. Neurol. Neurosurg. Psychiatry 77: 154-158 [Abstract] [Full Text]